CRISPR-Cas9 Gene editing system, non-complex technology; complex patenting
Practices:Patents
Category:Others
Authors | YAMAMOTO, Osamu |
---|---|
Practice Areas | Patents |
Date of publication | Issue 3 2020 |
Publication carrying this article | The Life Sciences Lawyer |
Publisher | CTC Legal Media |
Summary
Mr. Yamamoto analyzes the patents in Japan on CRISPR-Cas9 Gene editing system, including the Intellectual Property High Court decisions on the two patent applications of Broad et al. rendered on February 25, 2020.
Other works by YAMAMOTO, Osamu
-
Publications Intellectual Property、Patents Cases
The gray area between patent rights and physician practice
YAMAMOTO, Osamu
-
Publications Intellectual Property、Patents Cases
Antibody Patenting – Second Edition –
YAMAMOTO, Osamu
-
Publications Intellectual Property、Patents Laws
Pharmaceutical Test Data Exclusivity
YAMAMOTO, Osamu
-
Publications Intellectual Property、Patents Laws
IP law in Japan : the recent changes
YAMAMOTO, Osamu
-
Publications
2022 – Study Question “Patentability of Diagnostic Methods”
YAMAMOTO, Osamu
Other works on Patents
-
Publications Intellectual Property、Patents Laws
Future of the Patent Attorney Industry and Use of AI – Joining the magazine discussions (considering the viewpoints on AI’s technological future) –
OKAMOTO, Yoshinori
-
Publications Intellectual Property、Patents Laws
The Amount of Damages Recoverable by Joint Patentees for Patent Infringement
FUKAI, Toshiyuki
-
Publications Intellectual Property、Patents Cases
The gray area between patent rights and physician practice
YAMAMOTO, Osamu
-
Publications Intellectual Property、Patents Laws
Article 102(2) of the Patent Act – The Necessity of Sale of Competitive Products by Patentees
FUKAI, Toshiyuki
-
Publications Intellectual Property、Patents Laws
The Effect of an Invention
FUKAI, Toshiyuki
Telephone
+81(3)3270-6641